Elizabeth A. McGlynn Named Director of Kaiser Permanente Center for Effectiveness & Safety Research

Published January 19, 2011

Elizabeth A. McGlynn Named Director of Kaiser Permanente Center for Effectiveness & Safety Research
OAKLAND, Calif., Jan. 18, 2011 /PRNewswire/ — Kaiser Permanente announced today that Elizabeth A. McGlynn, Ph.D., former associate director of RAND Health, has been named director of the Kaiser Permanente Center for Effectiveness and Safety Research. (Photo: http://photos.prnewswire.com/prnh/20110118/SF31299) The Center draws on over 400 Kaiser Permanente researchers …
Read more on redOrbit

Drugs offer hope for Hepatitis C
MEDICINE: New mix boosts effectiveness and may lead to more baby-boomer testing.
Read more on Daily Breeze

2 hepatitis C drugs near approval
WASHINGTON – There’s new hope for an overlooked epidemic: Two powerful drugs that promise to help cure many more people of liver-attacking hepatitis C are nearing Food and Drug Administration approval – even though most who have the simmering infection don’t know it yet.
Read more on Worcester Telegram & Gazette